TITLE

NEW GENERICS

PUB. DATE
July 2007
SOURCE
Drug Topics;7/9/2007, Vol. 151 Issue 13, p42
SOURCE TYPE
Trade Publication
DOC. TYPE
Product Review
ABSTRACT
The article evaluates generic drugs, including alprazolam extended-release tablets from Impax Laboratories and oxybutynin chloride extended-release tablets from Teva Pharmaceuticals.
ACCESSION #
25886325

 

Related Articles

  • NEW GENERICS.  // Drug Topics;1/8/2007, Vol. 151 Issue 1, p59 

    The article evaluates the Ondansetron injection from Teva Pharmaceuticals USA Inc. and glipizide ER tablets from Actavis Group.

  • NEW GENERICS.  // Drug Topics;7/23/2007, Vol. 151 Issue 14, p68 

    The article evaluates several generic drugs including Watson Pharmaceuticals Inc.'s Bupropion HCl extended-release tablets and Teva Pharmaceuticals USA Inc.'s Dexmethylphenidate hydrochloride tablets.

  • NEW GENERICS.  // Drug Topics;9/3/2007, Vol. 151 Issue 17, p46 

    The article evaluates several generic drugs including Abraxis Pharmaceutical Products' cefotetan disodium for injection, Teva Health Systems' Ifosfamide injection and Teva Pharmaceuticals USA Inc.'s pantoprazole sodium delayed-disease (DR) tablets.

  • NEW GENERICS.  // Drug Topics;9/4/2006, Vol. 150 Issue 17, p73 

    The article evaluates newly approved generics drugs including meloxicam tablets from Breckenridge Pharmaceutical, metformin extended-release tablets from Synovics Pharmaceuticals and venlfaxine hydrochloride tablets from TEVA Pharmaceuticals.

  • NEW GENERICS.  // Drug Topics;3/5/2007, Vol. 151 Issue 5, p58 

    The article evaluates several generic drugs approved by the U.S. Food and Drug Administration including Teva Pharmaceuticals USA Inc.'s angiotensin converting enzyme inhibitor Trandolapril tablets, Ranbaxy Pharmaceuticals Inc.'s atenolol tablets for the treatment of hypertension and Barr...

  • New Products.  // Drug Topics;8/20/2007, Vol. 151 Issue 16, p72 

    The article evaluates new drugs, including Privegen from CSL Behring Co., Advate from Baxter Healthcare Corp., and terbinafine hydrochloride tablets, a generic drug, from Teva Pharmaceuticals Ltd.

  • NEW GENERICS.  // Drug Topics;6/5/2006, Vol. 150 Issue 11, p45 

    The article reports on the approval of several drugs by the U.S. Food and Drug Administration (FDA) in 2006. FDA approved pilocarpine hydrochloride, manufactured by Impax Laboratories Inc. for treating symptoms of dry mouth in Sjogren's syndrome patients. Pilocarpine is a generic version of...

  • NEW GENERICS.  // Drug Topics;8/6/2007, Vol. 151 Issue 15, p51 

    The article evaluates several generic drugs from Teva Pharmaceuticals including the Amlodipine Besylate tablets for treatment of hypertension, chronic stable angina and vasosplastic angina, the Ondansetron Hydrochloride tablets used as an antiemetic for cancer chemotherapy and radiation, and the...

  • New drugs and dosage forms.  // American Journal of Health-System Pharmacy;8/15/2009, Vol. 66 Issue 16, p1422 

    The article evaluates several drugs, including the Ferumoxytol injection from AMAG Pharmaceuticals Inc., Levonorgestrel tablets from Teva Pharmaceuticals USA Inc., and Prasugrel tablets from Eli Lilly & Co.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics